iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
75 hedge funds and large institutions have $46.1M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
Holders
75
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.54M | |
| 2 | +$1.23M | |
| 3 | +$791K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$717K |
| 5 |
PP
Prudential plc
London, England,
United Kingdom
|
+$665K |
Top Sellers
| 1 | -$1.63M | |
| 2 | -$679K | |
| 3 | -$528K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$394K |
| 5 |
KAS
Kestra Advisory Services
Austin,
Texas
|
-$323K |